federal_register: 2012-30516
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2012-30516 | Impact of Approved Drug Labeling on Chronic Opioid Therapy; Public Hearing; Request for Comments | Notice | The Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain. | 2012-12-19 | 2012 | 12 | https://www.federalregister.gov/documents/2012/12/19/2012-30516/impact-of-approved-drug-labeling-on-chronic-opioid-therapy-public-hearing-request-for-comments | https://www.govinfo.gov/content/pkg/FR-2012-12-19/pdf/2012-30516.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA) is announcing a public hearing to obtain information, particularly scientific evidence, such as study data or peer-reviewed analyses, on issues pertaining to the use of opioid drugs in the treatment of chronic pain. |